numbers cut at Credit Suisse. GDI estimates were reduced through 2013, Credit Suisse said. Company is seeing lower expected growth. Neutral rating and new $78 price target.
Michael Kors Holdings
numbers raised at Jefferies. Shares of KORS now seen reaching $40, Jefferies said. Estimates also raised on strong holiday season. Buy rating.
target raised at Jefferies to $53, Jefferies said. Outlook improving in the first half of 2012. Buy rating.
LyondellBasell estimates, target raised at Goldman. Shares of LYB now seen reaching $54, according to Goldman Sachs. Estimates also increased, as the company is realizing higher margins. Buy rating.
LyondellBasell numbers raised at UBS. Shares of LYB now seen reaching $50, according to UBS. Estimates also increased to reflect cheaper ethane. Buy rating.
target raised at UBS. MAT price target increased to $36, UBS said. Earnings outperformance poised to continue. Buy rating.
estimates, target raised at Morgan Stanley. Shares of MRK now seen reaching $37, according to Morgan Stanley. Estimates also increased, given higher expectations for Vytorin. Equal-weight rating.
(MU - Get Report)
target raised at Oppenheimer. Shares of MU now seen reaching $9.50, Oppenheimer said. Solid analyst day. Outperform rating.
Omega Healthcare Investors
numbers raised at Jefferies. Shares of OHI now seen reaching $24, Jefferies said. Estimates also raised on risk of tenant rent defaults at OHI is low. Buy rating.
(PEP - Get Report)
estimates lowered at UBS through 2013, UBS said. Strategy in place, but to early to tell if it will be successful. Neutral rating and $64 price target.
added to US 1 List at BofA/Merrill. Valuation call, based on a $110 price target.
>To submit a news tip, email:
and become a fan on